A detailed history of Cfo4 Life Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cfo4 Life Group, LLC holds 2,696 shares of NVO stock, worth $385,474. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,696
Previous 2,271 18.71%
Holding current value
$385,474
Previous $234,000 47.86%
% of portfolio
0.06%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $43,396 - $57,765
425 Added 18.71%
2,696 $346,000
Q4 2023

Jan 24, 2024

SELL
$87.78 - $105.45 $7,549 - $9,068
-86 Reduced 3.65%
2,271 $234,000
Q3 2023

Oct 30, 2023

BUY
$90.94 - $199.54 $214,345 - $470,315
2,357 New
2,357 $214,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $323B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cfo4 Life Group, LLC Portfolio

Follow Cfo4 Life Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfo4 Life Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfo4 Life Group, LLC with notifications on news.